Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study

A J Slooter1, C M van Duijn, M L Bots

  • 1Department of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.

Journal of Neural Transmission. Supplementum
|August 13, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association of arterial stiffness and arterial calcification: the Rotterdam study.

Journal of human hypertension·2008
Same author

Haplotypes of the fibrinogen gene and cerebral small vessel disease: the Rotterdam scan study.

Journal of neurology, neurosurgery, and psychiatry·2007
Same author

Explaining differences in birthweight between ethnic populations. The Generation R Study.

BJOG : an international journal of obstetrics and gynaecology·2007
Same author

The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.

European journal of epidemiology·2007
Same author

Relation between smoking and risk of dementia and Alzheimer disease: the Rotterdam Study.

Neurology·2007
Same author

Fetal kidney volume and its association with growth and blood flow in fetal life: The Generation R Study.

Kidney international·2007

The apolipoprotein E4 allele (APOE ε4) and atherosclerosis interact to increase cognitive decline risk. APOE ε4 carriers with atherosclerosis showed significantly lower cognitive scores, indicating a combined detrimental effect.

Area of Science:

  • Neuroscience
  • Genetics
  • Cardiovascular Science

Background:

  • Apolipoprotein E4 allele (APOE ε4) is a known genetic risk factor for cognitive decline.
  • Atherosclerosis, a cardiovascular condition, is also associated with impaired cognitive function.
  • The independent or interactive effects of APOE ε4 and atherosclerosis on cognitive decline remain unclear.

Purpose of the Study:

  • To investigate whether the effects of APOE ε4 and atherosclerosis on cognitive decline are independent or interactive.
  • To determine the combined impact of genetic predisposition (APOE ε4) and vascular disease (atherosclerosis) on cognitive function.

Main Methods:

  • A population-based follow-up study involving 838 non-demented subjects at baseline.
  • Assessment of cognitive decline using the Mini Mental State Examination (MMSE) score at follow-up.

Related Experiment Videos

  • Analysis of cognitive scores as a function of APOE ε4 status and indicators of atherosclerosis.

    • Main Results:

    • Mild, non-significant effects on MMSE scores were observed for atherosclerosis alone or APOE ε4 alone.
    • APOE ε4 carriers with two or more indicators of atherosclerosis exhibited significantly lower MMSE scores at follow-up (mean difference -0.7 points).
    • This difference was relative to non-APOE ε4 carriers without evidence of atherosclerosis.

    Conclusions:

    • The detrimental effects of APOE ε4 and atherosclerosis on cognitive decline are not independent; they interact synergistically.
    • APOE ε4 carriers who also have atherosclerosis face a substantially increased risk of cognitive decline.
    • These findings highlight the critical interplay between genetic predisposition and vascular health in maintaining cognitive function.